248 related articles for article (PubMed ID: 15372423)
1. Pantoprazole-induced acute interstitial nephritis.
Moore I; Sayer JA; Nayar A; Ahmed S; Tapson JS
J Nephrol; 2004; 17(4):580-1. PubMed ID: 15372423
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitors and acute interstitial nephritis.
Geevasinga N; Coleman PL; Webster AC; Roger SD
Clin Gastroenterol Hepatol; 2006 May; 4(5):597-604. PubMed ID: 16630752
[TBL] [Abstract][Full Text] [Related]
3. Acute interstitial nephritis due to pantoprazole.
Ra A; Tobe SW
Ann Pharmacother; 2004 Jan; 38(1):41-5. PubMed ID: 14742791
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
van Zyl J; van Rensburg C; Vieweg W; Fischer R
Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
[TBL] [Abstract][Full Text] [Related]
5. Rabeprazole-induced acute interstitial nephritis.
Geevasinga N; Coleman PL; Roger SD
Nephrology (Carlton); 2005 Feb; 10(1):7-9. PubMed ID: 15705174
[TBL] [Abstract][Full Text] [Related]
6. Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.
Jacobs-Kosmin D; Derk CT; Sandorfi N
J Rheumatol; 2006 Mar; 33(3):629-32. PubMed ID: 16482642
[TBL] [Abstract][Full Text] [Related]
7. Recurrent anaphylaxis linked to pantoprazole.
Kollmeier AP; Eddleston J; Zuraw BL; Christiansen SC
J Allergy Clin Immunol; 2004 Oct; 114(4):975-7. PubMed ID: 15480345
[No Abstract] [Full Text] [Related]
8. [2 new proton pump inhibitors. Possibilities of pantoprazole and lansoprazole].
Leonhardt U; Ritzel U; Ramadori G
Internist (Berl); 1996 Sep; 37(9):944-9; discussion 949. PubMed ID: 8964694
[No Abstract] [Full Text] [Related]
9. Pantoprazole-induced thrombocytopenia.
Watson TD; Stark JE; Vesta KS
Ann Pharmacother; 2006 Apr; 40(4):758-61. PubMed ID: 16569810
[TBL] [Abstract][Full Text] [Related]
10. Pantoprazole versus omeprazole in the treatment of reflux esophagitis.
Vcev A; Stimac D; Vceva A; Takac B; Ivandić A; Pezerović D; Horvat D; Nedić P; Kotromanović Z; Maksimović Z; Vranjes Z; Males J; Jurisić-Orzen D; Vladika I; Stimac T; Mandić B
Acta Med Croatica; 1999; 53(2):79-82. PubMed ID: 10705625
[TBL] [Abstract][Full Text] [Related]
11. Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease.
Kaspari S; Kupcinskas L; Heinze H; Berghöfer P
Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):935-41. PubMed ID: 16093871
[TBL] [Abstract][Full Text] [Related]
12. Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease.
Tolia V; Bishop PR; Tsou VM; Gremse D; Soffer EF; Comer GM;
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):384-91. PubMed ID: 16641576
[TBL] [Abstract][Full Text] [Related]
13. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
[TBL] [Abstract][Full Text] [Related]
14. Pantoprazole for sleepiness associated with acid reflux and obstructive sleep disordered breathing.
Steward DL
Laryngoscope; 2004 Sep; 114(9):1525-8. PubMed ID: 15475774
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.
Wurzer H; Schutze K; Bethke T; Fischer R; Luhmann R; Riesenhuber C
Hepatogastroenterology; 1999; 46(27):1809-15. PubMed ID: 10430350
[TBL] [Abstract][Full Text] [Related]
16. Nonallergic anaphylaxis to pantoprazole.
Kaatz M; Bauer A; Hipler C; Elsner P
Allergy; 2002 Feb; 57(2):184. PubMed ID: 11929432
[TBL] [Abstract][Full Text] [Related]
17. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
Schepp W; Rehner M; Witzel L
Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
[TBL] [Abstract][Full Text] [Related]
18. Effect of corticosteroids during ongoing drug exposure in pantoprazole-induced interstitial nephritis.
Kim MJ; Heim M; Mayr M
Nephrol Dial Transplant; 2010 May; 25(5):1716-9. PubMed ID: 20067906
[TBL] [Abstract][Full Text] [Related]
19. [Financial restrictions in health care systems could affect treatment quality of GERD-patients].
Gillessen A; Schöffel L; Naumburger A
Z Gastroenterol; 2006 May; 44(5):379-85. PubMed ID: 16688654
[TBL] [Abstract][Full Text] [Related]
20. Elevated quetiapine serum concentrations in a patient treated concomitantly with doxepin, lorazepam, and pantoprazole.
Härtter S; Connemann B; Schönfeldt-Lecuona C; Sachse J; Hiemke C
J Clin Psychopharmacol; 2004 Oct; 24(5):568-71. PubMed ID: 15349025
[No Abstract] [Full Text] [Related]
[Next] [New Search]
